Ocuphire Pharma Inc. (OCUP) Social Stream



Ocuphire Pharma Inc. (OCUP): $1.61

0.08 (+4.89%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add OCUP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#43 of 359

in industry

OCUPHIRE PHARMA INC (OCUP) Price Targets From Analysts

Use the tables below to see what analysts covering OCUPHIRE PHARMA INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 3 $25 $22 $22.75 $3.25 600%
2021-11-24 4 $26 $22 $24.333 $3.25 648.71%
2022-03-25 3 $26 $22 $24.333 $3.25 648.71%
2022-03-30 2 $26 $23 $24.5 $3.25 653.85%
2022-05-16 2 $26 $21 $23.5 $3.25 623.08%
2022-11-07 2 $26 $24 $25 $3.25 669.23%
2022-11-09 2 $26 $22 $24 $3.25 638.46%
2023-05-16 2 $24 $20 $22 $3.25 576.92%
2023-08-14 2 $22 $17 $19.666 $3.25 505.11%
2023-11-03 2 $22 $16 $19.333 $3.25 494.86%
2023-11-14 2 $20 $16 $18 $3.25 453.85%

The Trend in the Analyst Price Target


Over the past 27 months, OCUP's average price target has gone down $4.75.

Over the past 42 weeks, OCUP's average upside potential has been 461.49%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-31 2 24 20 22.000 3.75 486.67%
2023-04-03 2 24 20 22.000 4.51 387.8%
2023-11-03 2 20 16 18.000 2.74 556.93%
2023-11-03 2 22 16 19.333 2.74 605.58%
2023-11-14 2 20 16 18.000 3.21 460.75%

OCUP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


OCUP's average broker recommendation rating improved by 0 over the prior 26 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • OCUPHIRE PHARMA INC's upside potential (average analyst target price relative to current price) is higher than 1428.23% of all US stocks.
  • In terms of how OCUPHIRE PHARMA INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 92.24% of that group.
  • OCUPHIRE PHARMA INC's variance in analysts' estimates is lower than -24.94% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the micro market cap category, OCUPHIRE PHARMA INC's average analyst price target is higher than 1231.64% of them.

Stocks similar to OCUPHIRE PHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CPHI, PRPH, and QLI.

Is OCUP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!